NIH Reporter #RFA-DA-23-012

NIDA Research Grant: Synthetic Fentanyls and NeuroHIV at University of Florida

This opportunity is a research grant solicitation from the National Institute on Drug Abuse (NIDA) for the University of Florida's Department of Pathology in Gainesville, FL. - Government Buyer: - National Institute on Drug Abuse (NIDA), part of the National Institutes of Health (NIH) - Targeted at the University of Florida, Department of Pathology - Products/Services Requested: - Research on the effects of synthetic fentanyls on the blood-brain barrier and HIV replication in the context of neuroHIV - Activities include: - Analysis of blood-brain barrier permeability - Investigation of HIV infection in microglia - Exploration of molecular mechanisms underlying blood-brain barrier dysfunction - OEMs and Vendors: - No specific OEMs or commercial vendors are named in the notice - Unique/Notable Requirements: - Research must focus on neuroHIV and synthetic opioids - Requires expertise in blood-brain barrier research - Led by Dr. Allison Michelle Andrews - Structured as a research grant, not a procurement of goods or commercial services

Description

This is a research grant opportunity focused on studying the effects of synthetic fentanyls on the blood-brain barrier and HIV replication within the context of neuroHIV. The project includes multiple aims such as analyzing blood-brain barrier permeability, HIV infection in microglia, and the molecular mechanisms underlying blood-brain barrier dysfunction. The research is led by Dr. Allison Michelle Andrews at the University of Florida. The award amount is approximately $668,098 for fiscal year 2026, and the application deadline is June 9, 2026.

View original listing